SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Stifel Maintains Buy on Ultragenyx Pharmaceutical, Raises Price Target to $82

Stifel maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $70 to $82.

Benzinga · 05/18/2020 14:05

Stifel maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $70 to $82.